期刊文献+

EIF5A2基因在不同发育时期人胎盘绒毛膜中的定位表达及意义

Expression and localization of EIF5A2 in human placental chorion at different developmental stages
下载PDF
导出
摘要 目的探讨EIF5A2(eukaryotic transla-tion initiation factor 5A2)癌基因在人胎盘绒毛膜中表达及其定位。方法收集孕早期(8±周)绒毛膜、孕中期(20±周)及足月(38±周)胎盘组织,应用RT-PCR和Western blot及免疫组织化学等方法,从分子水平及蛋白水平检测EIF5A2在不同时段胎盘组织中的表达及定位。结果 RT-PCR及Western blot检测结果显示各期胎盘组织中均有EIF5A2 mRNA及蛋白表达,孕中期达峰值,足月胎盘EIF5A2表达显著下降(P<0.05);免疫组化结果显示孕早期绒毛膜中EIF5A2定位表达于合体滋养层及细胞滋养层细胞胞质,孕中期胎盘组织中EIF5A2主要表达于细胞滋养层,合体滋养层表达较弱,分娩期胎盘部分合体滋养层细胞内可见微弱的EIF5A2表达。结论 EIF5A2在不同时段人绒毛膜、胎盘组织中均有表达,定位于胎盘绒毛膜合体滋养层及细胞滋养层细胞胞质,其表达丰度及优势表达细胞类别在不同孕期存在差异。 Objective To explore the expression and localization of oncogene EIF5A2 in human placental chorion at different stages.Methods Immunohistochemistry(IHC) staining,reverse transcription-PCR(RT-PCR) and Western blot were used to investigate the expression and localization of EIF5A2 in human placental chorion.Results RT-PCR and Western blot showed that EIF5A2 mRNA and protein expression were found at different stages in human placenta,and they were the highest in the midtrimester and the lowest in the term placenta(P 〈 0.05). Immunohistochemistry showed that EIF5A2 expressed in cytoplasm of both syncytiotrophoblast and cytotrophoblast in the first trimester.In the midtrimester,EIF5A2 mainly espressed in cytotrophoblast,and weakly in syncytiotrophoblast.In the term placenta,only in part of syncytiotrophoblast was there weak EIF5A2 expression.Conclusion EIF5A2 expresses at different stages in human placenta,which is localized in both syncytiotrophoblast and cytotrophoblast,and the expression level and the cells of predominant expression are different at developmental stages.
出处 《山西医科大学学报》 CAS 2014年第8期692-695,784,共5页 Journal of Shanxi Medical University
基金 广州市教育局高校科技计划基金资助项目(61053)
关键词 EIF5A2 绒毛膜 合体滋养层 细胞滋养层 胎盘 EIF5A2 chorion syncytiotrophoblast cytotrophoblast placenta
  • 相关文献

参考文献11

  • 1孟庆彬,于健春,马志强.EIF5A2在肿瘤中的作用研究进展[J].基础医学与临床,2013,33(1):123-125. 被引量:8
  • 2Clement PMJ,Henderson CA,Jenkins ZA,et al.Identification and characterization of eukaryotic initiation factor 5A2[J].Eur J Biochem,2003,270 (21):4254-4263.
  • 3Guan XY,Sham JS,Tang TC,et al.Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer[J].Cancer Res,2001,61 (9):3806-3809.
  • 4Jenkins ZA,Haag PG,Johansson HE.Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expressio[J].Genomics,2001,71 (1):101-109.
  • 5Yang GF,Xie D,Liu JH,et al.Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF5A2 is a new independent predictor of outcome in patients with ovarian carcinoma[J].Gynecol Oncol,2009,112(2):314-318.
  • 6Cao D,Hustinx SR,Sui G,etal.Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags[J].Cancer Biol The,2004,3 (11):1081-1089.
  • 7Zhu W,Cai MY,Tong ZT,et al.Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-MYC to induce epithelial-mesenchymal transition[J].Gut,2011,61 (4):562-575.
  • 8Luo JH,Hua WF,Rao HL,et al.Overexpression of EIF5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder[J].Cancer Sci,2009,100 (5):896-902.
  • 9Tang DJ,Dong SS,Ma NF,et al.Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma[J].Hepatology,2010,51(4):1255-1263.
  • 10He LR,Zhao HY,Li BK,et al.Overexpression of eIF5 A-2 is an adverse prognostic marker of survival instage I non-small cell lung cancer patients[J].Int J Cancer,2011,129 (1):143-150.

二级参考文献42

  • 1Dierick H, Bejsovec A. Cellular mechanisms of wingless/Wnt signal transduction. Curr Top Dev Biol, 1999,43:153-190.
  • 2Wang Y, Macke JP, Abella BS, et al. A large family of putative transmembrane receptors homologous to the product of the Dorsophlia tissue polarity gene frizzled. J Biochem,1996,271(8): 4468-4476.
  • 3Miller JR. The Wnts. Genome Biol, 2002,3(1): 1-15.
  • 4Miller JR, Hocking AM, Brown JD, et al. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2 + pathways. Oncogene, 1999,18(55):7860-7872.
  • 5Waltzer L,- Bienz M.The control of beta-catenin and TCF during embryonic development and cancer. Cancer Metastasis Rev, 1999,18(2): 231-246.
  • 6Tulae S, Nayak NR, Kao LC, et al. Identification, characterization,and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab, 2003,88(8): 3860-3866.
  • 7Paria BC, Ma W, Tan J, et al. Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc Natl Acad Sci U S A, 2001,98 (3):1047-1052.
  • 8Miller C, Sassoon DA.Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract.Development, 1998, 125(16): 3201-3211.
  • 9Taylor HS, Arici A, Olive D, et al. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium.J Clin Invest, 1998,101 (7):1379-1384.
  • 10Taylor HS, Igarashi P, Olive DL, et al. Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium. J Clin Endocrinol Metab, 1999,84(3):1129-1135.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部